SCHEMBL8134359

SCHEMBL8134359

Clc1ccc(CN2CCN(c3nccc4ccccc34)CC2)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.58
KMT2A Q03164 3/20 0.58
HRH4 Q9H3N8 1/20 0.58
HTR2C P28335 1/20 0.55
MAPT P10636 3/20 0.53
KDM4E B2RXH2 2/20 0.53
RECQL P46063 1/20 0.53
NPSR1 Q6W5P4 1/20 0.53
SIGMAR1 Q99720 1/20 0.53
SORD Q00796 2/20 0.52
ACHE P22303 3/20 0.52
ALDH1A1 P00352 3/20 0.51
LMNA P02545 2/20 0.51
HPGD P15428 1/20 0.51
DRD4 P21917 1/20 0.50
BACE1 P56817 1/20 0.49
SMN1; SMN2 Q16637 2/20 0.48
HIF1A Q16665 2/20 0.48
TDP1 Q9NUW8 1/20 0.48
HTR1A P08908 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Oxalic Acid SCHEMBL8149109 0.93 HRH4 (0.51) MEN1KMT2AHRH4HTR2CMAPT
SCHEMBL6232120 0.91 HRH4 (0.62) HRH4HTR2CMAPTKDM4ENPSR1
SCHEMBL3684916 0.88 KDM4E (0.59) MEN1KMT2AHRH4HTR2CMAPT
SCHEMBL8486348 0.88 HRH4 (0.60) MEN1KMT2AHRH4HTR2CMAPT
SCHEMBL8130723 0.88 SIGMAR1 (0.58) MEN1KMT2AHRH4HTR2CMAPT
SCHEMBL8124752 0.86 KMT2A (0.57) KMT2AHRH4HTR2CMAPTKDM4E
SCHEMBL8118469 0.85 HRH4 (0.53) MEN1KMT2AHRH4HTR2CMAPT
Hydrochloric Acid SCHEMBL8110649 0.85 KMT2A (0.56) KMT2AHRH4HTR2CMAPTKDM4E
SCHEMBL3684760 0.85 HTR3E (0.53) MEN1KMT2AHTR2CMAPTKDM4E
Hydrochloric Acid SCHEMBL31587046 0.84 HRH4 (0.55) HRH4HTR2CMAPTKDM4ESORD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0970054-A1 1-(ISOQUINOLIN-1-YL)-4-(1-PHENYLMETHYL)PIPERAZINES; DOPAMINE RECEPTOR SUBTYPE SPECIFIC LIGANDS NEUROGEN CORPORATION (US) 2000-01-12 EP claimed
US-6008352-A USEFUL IN TREATING PSYCHOTIC DISORDERS SUCH AS SCHIZOPHRENIA AND OTHER CENTRAL NERVOUS SYSTEM DISEASES NEUROGEN CORPORATION (US) 1999-12-28 US claimed
WO-1998039301-A1 1-(ISOQUINOLIN-1-YL)-4-(1-PHENYLMETHYL)PIPERAZINES; DOPAMINE RECEPTOR SUBTYPE SPECIFIC LIGANDS NEUROGEN CORPORATION (US) 1998-09-11 WO claimed